https://www.avient.com/sites/default/files/2022-04/Avient Announces Agreement to Acquire Dyneema_0.pdf
Factors that could cause
actual results to differ materially from those implied by these forward-looking statements include,
but are not limited to: the time required to consummate the acquisition of the Dyneema business;
the satisfaction or waiver of conditions in the purchase agreement; completion of the consultation
process with the relevant Dutch works council; the ability to obtain required regulatory or other
third-party approvals and consents and otherwise consummate the proposed acquisition of the
Dyneema business; our ability to achieve the strategic and other objectives relating to the
proposed acquisition of the Dyneema business and possible sale of the distribution business;
disruptions, uncertainty or volatility in the credit markets that could adversely impact the
availability of credit already arranged and the availability and cost of credit in the future; the effect
on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory
risks; the current and potential future impact of the COVID-19 pandemic on our business, results
of operations, financial position or cash flows; changes in polymer consumption growth rates and
laws and regulations regarding plastics in jurisdictions where we conduct business; fluctuations
in raw material prices, quality and supply, and in energy prices and supply; production outages
or material costs associated with scheduled or unscheduled maintenance programs;
unanticipated developments that could occur with respect to contingencies such as litigation and
environmental matters; an inability to raise or sustain prices for products or services; information
systems failures and cyberattacks; and other factors affecting our business beyond our control,
including without limitation, changes in the general economy, changes in interest rates and
changes in the rate of inflation.
https://www.avient.com/sites/default/files/2025-03/65537-Certificate-05MAR2025.pdf
Industrial Valle del Cinca S/N
Apartado , E-22300 Barbastro, Spain
Avient Corporation Design and Manufacture of Colorants and Compounds for Fluoropolymer
and High Temperature Polymers.
19 Francis J Clark Circle Bethel CT
06801 United States
Avient Corporation Design and Manufacture of Colorants and Additives for Plastics 03 Street 02, VSIP 820000 Thuận An
Binh Duong Vietnam
Avient Corporation Design and Manufacture of Colorants and Additives for Plastics Lot 1232, MK. 15, Kawasan Industri,
Kecil & Sederhana Butterworth
Penang 14120 Malaysia
Avient Corporation Design and Manufacture of Colorants and Additives for Plastics Autopista Medellín Km 2.5, Via
Parcelas Km 1, Vereda Siberia ,
250017 Cota, Colombia
Ihsan Dede Cad. , 41448 Gebze,
Türkiye
Avient Corporation Design and Manufacture of Colorants and Additives for Plastics 2#, Nanyunsan Rd, Huangpu District,
Science City, Guangzhou Hi-Tech
Industrial Development Zone ,
510663 Guangzhou,
Avient Corporation Design and Manufacture of Colorants and Additives for Plastics Avenida 34-11, Zona 12 Complejo
Parque Gobal , 01012 Guatemala
City, Guatemala
Avient Corporation Design and Manufacture of Specialty Engineered Thermoplastics Orhangazi Mah. 1683 Sok.
https://www.avient.com/sites/default/files/2024-10/Avient_CodeConduct_2024_final2.pdf
OUR CODE
OF CONDUCT
ISSUED OCTOBER 2024
TABLE OF
CONTENTS
Introduction:
A Message from the CEO 1
Guidelines for Ethical Behavior 3
Personal Values 3
Your Responsibilities 4
Additional Responsibilities of
Avient Supervisors and Managers 4
Resolving Questions and Reporting
Non-Compliance Situations 5
Ethics Hotline 5
Non Retaliation 6
Code of Conduct Application 6
Violations of the Code 6
Diversity and Inclusion 8
Discrimination or Harassment 8
Workplace Relationships 9
Substance Abuse 10
Physical Security and
Workplace Violence 10
Accurate Information,
Data and Records 12
Accounting Integrity 12
Company Communications 14
Safeguarding and Use of Assets 14
Proprietary and Confidential
Information, Ideas and
Intellectual Property 15
Privacy, Personal Information
and Data Protection 16
Internet and E-mail Use 16
Social Media and
Social Networking 17
Computer Security, Software
Licensing and Copyrights 17
Insider Information and Trading 18
Political Contributions/Activities
and Charitable Contributions 19
Government Investigations
and Inquiries 19
Integrity in Our
Business
Fair Dealing 21
Bribery and Kickbacks 21
Agents and Consultants 22
Competition 22
Gifts and Hospitality 23
Conflicts of Interest 24
Self-Dealing 25
International Trade 25
Money Laundering 25
Corporate Social
Responsibility
Sustainability 27
Safety, Health and Environment 28
Product and Service Safety 29
Respecting Human Rights 29
A Shared Commitment 29
Resources and
Contact Information
Our Policies 30
Internal Contacts 30
Ethics Hotline 30
A Message from the CEO
Dear Avient Team,
Our company decisions have far-reaching implications in today’s complex and interconnected world.
OUR CODE OF
INTEGRITY IN OUR
CORPORATE SOCIAL
CODE OF CONDUCT | 19
CODE OF CONDUCT | 20
Integrity in Our Business
It is critical that Avient maintain high ethical standards in
all our business dealings, including our relationships with
customers and vendors.
Francisco
Nakasato, 1700
13295-000 Itupeva
Sao Paulo, Brazil
Telephone: +55 11 4593 9200
Europe
Pommerloch, Luxembourg
19 Route de Bastogne
Pommerloch, Luxembourg,
L-9638
Telephone: +352 269 050 35
Fax: +352 269 050 45
www.avient.com
https://www.avient.com
Acknowledgment of Compliance with Avient’s Code of Conduct
Instructions:
Please read, sign and return this document to Human Resources.
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_USA.pdf
Our Code of
Conduct
2023
Table of Contents
A Message from the CEO 1
Our Vision and Strategy 2
Core and Personal Values 2
Our Code of Conduct
Guidelines for Ethical Behavior 4
Personal Values 4
Resolving Questions and Reporting
Non-Compliance Situations 6
Ethics Hotline 6
Non Retaliation 6
Code of Conduct Application 7
Violations of the Code 7
Respect for All
Diversity and Inclusion 9
Discrimination or Harassment 9
Workplace Relationships 9
Substance Abuse 10
Physical Security and Workplace Violence 10
Honesty at Work
Accurate Information, Data and Records 12
Accounting Integrity 12
Company Communications 14
Safeguarding and Use of Assets 14
Proprietary and Confidential Information,
Ideas and Intellectual Property 14
Privacy, Personal Information and
Data Protection 15
Internet and E-mail Use 15
Social Media and Social Networking 15
Computer Security, Software Licensing
and Copyrights 16
Insider Information and Trading 16
Political Contributions/Activities and
Charitable Contributions 17
Government Investigations and Inquiries 17
Integrity in Our Business
Fair Dealing 19
Bribery and Kickbacks 19
Agents and Consultants 20
Competition 20
Gifts and Hospitality 20
Conflicts of Interest 21
Self-Dealing 22
International Trade 22
Corporate Social Responsibility
Sustainability 24
Safety, Health and Environment 24
Product and Service Safety 25
Respecting Human Rights 25
A Shared Commitment 25
Resources and Contact
Information 26
1
A Message from the CEO
Dear Avient Associates,
As part of a growing, global company, we are faced with challenging situations and complex decision making.
Our personal integrity is the foundation for Avient’s reputation,
and integrity builds credibility.
19
Fair Dealing
We sell our products and services on their merits.
Francisco
Nakasato, 1700
13295-000 Itupeva
Sao Paulo, Brazil
Telephone: +55 11 4593 9200
Europe
Pommerloch, Luxembourg
19 Route de Bastogne
Pommerloch, Luxembourg,
L-9638
Telephone: +352 269 050 35
Fax: +352 269 050 45
www.avient.com
https://www.avient.com
https://www.avient.com/sites/default/files/2021-10/microbial-susceptibility-of-various-polymers-and-evaluation.pdf
The global
antimicrobial plastics market is forecasted to grow signifi-
cantly from 36.9 billion to 59.8 billion USD during 2020–
2025, a compound annual growth rate of 10.1%.[3] Similar
to the specialty biocides market, the outbreak of COVID-
19 has undoubtedly increased consumer cognizance of
high-touch plastic surfaces (e.g., phone cases, point-of-
purchase equipment, shopping carts, etc.).
To reduce the incidence of device-associated infections,
antimicrobial technologies have been utilized in a variety
of ways ranging from bulk-imbedded additives to sur-
face grafting techniques.[13,14] In particular, silver-based
additive technologies are frequently explored for
healthcare applications due to their favorable toxicological
profiles and broader regulatory approvals, while silver
nanoparticles with controlled, long-term release profiles
continue to be a very active and promising area of biomedi-
cal research.[15-19] In textile segments such as sports active-
wear, biocides are used to prevent the growth of odor-
causing bacteria from perspiration.[20,21] Additionally,
high-end recreational products such as boats utilize bio-
cides to preserve the aesthetics of PVC products used for
seat covers since bacterial growth may lead to pink staining
caused by specific bacterial metabolites.[22,23] With respect
to the mechanism of action, many antimicrobial products
work by attacking enzymes common to a variety of
microbes, interfering with membrane transport processes
(e.g., importing environmental copper into the cells) as
well as interfering with iron metabolism pathways.[24,25]
Herein, an assortment of both rigid and flexible resins/
compounds will be evaluated for susceptibility to determine
whether particular resin chemistries or compounds are
inherently vulnerable to microbial growth and subsequent
degradation or other deleterious effects.
Ortí-Lucas, JMBT
2015, 7, 398.
[19] E.
https://www.avient.com/sites/default/files/2021-09/avnt-seaport-conference-presentation.pdf
Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to:
• Disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future;
• The effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks;
• The current and potential future impact of the COVID-19 pandemic on our business, results of operations, financial position or cash flows including without any limitation, any supply chain and logistics issues
• Our ability to achieve the strategic and other objectives relating to the acquisition of Clariant’s Masterbatch business, including any expected synergies;
• Changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business;
• Fluctuations in raw material prices, quality and supply, and in energy prices and supply;
• Production outages or material costs associated with scheduled or unscheduled maintenance programs;
• Unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters;
• An inability to achieve the anticipated financial benefit from initiatives related to acquisition and integration working capital reductions, cost reductions and employee productivity goals;
• Our ability to pay regular quarterly cash dividends and the amounts and timing of any future dividends;
• Information systems failures and cyberattacks;
• Our ability to consummate and successfully integrate acquisitions;
• Amounts for cash and non-cash charges related to restructuring plans that may differ from original estimates, including because of timing changes associated with the underlying actions; and
• Other factors described in our Annual Report on Form 10-K for the year ended December 31, 2020 under Item 1A, “Risk Factors.”
In 2021, we expect substantial earnings growth and strong cash flow generation as we emerge from the
COVID-19 pandemic.
APPENDIX
Performance
Additives
Pigments
TiO2
Dyestuffs
4%Polyethylene
Nylon
Polypropylene
Other Raw
Materials
29%
Styrenic Block
Copolymer
~1/3 hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
34
• In Q2 2021, several raw material markets
experienced significant price inflation and
tight inventory
o Average cost of hydrocarbon based materials
was up 45% year-over-year and 20%
sequentially
o Average cost of non-hydrocarbon based
materials was up 10% year-over-year and 8%
sequentially
• Additionally, we experienced other supply
chain challenges during Q2 related to raw
material spot purchases, freight constraints
and productivity loss as a result of these
shortages
Annual Purchases
RAW MATERIAL AND SUPPLY CHAIN UPDATE
Based on 2020 pro forma purchases, excludes Distribution business
SEGMENT DATA
U.S. & Canada
50%
26%
Latin America
2021 YTD SEGMENT, END MARKET AND GEOGRAPHY
36
GEOGRAPHY REVENUESEGMENT FINANCIALS
23%
Building and
9%
END MARKET REVENUE
(1) Total company sales and EBITDA of $2,398M and $320M, respectively, include intercompany sales eliminations and corporate costs
All charts reflect YTD financials through June 30
$1,234M
$228M
$457M
$87M
$767M
$48M
Sales EBITDA
Distribution
Specialty Engineered Materials
Color Additives and Inks
$320M$2,398M
14%
34%
21%
Building &
9%
2% Telecommunications
C O L O R , A D D I T I V E S & I N K S
2021 YTD REVENUE | $1 .2 BILL ION
31%
42%
21%
Latin America
END MARKET REGION
37
S P E C I A LT Y E N G I N E E R E D M AT E R I A L S
28%
Building &
2021 YTD REVENUE | $457 MILLION
END MARKET
54%
26%
REGION
38
DI S TR IBU T I ON
27%
22%
Building and
81%
Latin
America
END MARKET REGION
K E Y S U P P L I ER S
2021 YTD REVENUE | $767 MILLION
39
TOTA L C O M PA N Y R E G I O N A L S A L E S
BY END MARKET
30%
27%Healthcare
Building &
2% Energy
(16% of sales)
32%
13%
18%
Building &
(26% of sales)
40
25%
19%
Building &
US &
Canada
(50% of sales)
13%
40%
33%
Building &
LATAM
(8% of sales)
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
June 30, 2021
Reconciliation to Condensed Consolidated Statements of Income
GAAP
Special
Adjusted
Operating income $ 108.1 $ 14.2 $ 122.3
Income from continuing operations before income taxes $ 89.8 $ 14.2 $ 104.0
Income tax expense - GAAP (20.4) — (20.4)
Income tax impact of special items — (3.4) (3.4)
Tax adjustments — 0.9 0.9
Net income attributable to noncontrolling interests (0.6) — (0.6)
Net income from continuing operations attributable to Avient shareholders $ 68.8 $ 11.7 $ 80.5
Net income / EPS $ 0.74 $ 0.13 $ 0.87
Weighted-average diluted shares 92.4 92.4 92.4
September 30, 2020
Reconciliation to Condensed Consolidated Statements of Income
GAAP
Special
Adjusted
Operating income $ 33.5 $ 40.4 $ 73.9
Income from continuing operations before income taxes $ 5.3 $ 50.0 $ 55.3
Income tax expense - GAAP (2.7) — (2.7)
Income tax impact of special items — (12.7) (12.7)
Tax adjustments — 3.0 3.0
Net income attributable to noncontrolling interests (0.9) — (0.9)
Net income from continuing operations attributable to Avient shareholders $ 1.7 $ 40.3 $ 42.0
Net income / EPS $ 0.02 $ 0.44 $ 0.46
Weighted-average diluted shares 91.9 91.9 91.9
Three Months Ended
Year Ended
December 31,
Reconciliation to Pro Forma Adjusted EBITDA
2021
March 31,
2021
June 30,
2020 2020 2019
Net income from continuing operations – GAAP $ 69.4 $ 79.7 $ 23.4 $ 133.8 $ 75.7
Income tax expense 20.4 22.9 7.9 5.2 33.7
Interest expense 19.5 19.3 16.2 74.6 59.5
Depreciation and amortization from continuing operations 33.8 37.1 20.9 115.0 78.1
EBITDA $ 143.1 $ 159.0 $ 68.4 $ 328.6 $ 247.0
Special items, before tax 14.2 2.4 2.4 66.2 61.7
Interest expense included in special items — — (0.5) (10.1) —
Depreciation and amortization included in special items 1.4 (0.5) (1.2) (3.2) —
Adjusted EBITDA $ 158.7 $ 160.9 $ 69.1 $ 381.6 $ 308.7
Clariant MB pro forma adjustments(1) — — 37.0 75.1 133.2
Pro forma adjusted EBITDA $ 158.7 $ 160.9 $ 106.1 $ 456.7 $ 441.9
(1) Pro forma adjustments for the periods prior to the acquisition date (July 1, 2020) and to give effects to the financing for the acquisition
1
Reconciliation of EBITDA by Segment
Six
Months
Ended
December 31,
2021 2020 2021 2020 2019 2018
Sales:
Color, Additives and Inks $ 624.4 $ 226.8 $ 1,233.7 $ 483.3 $ 1,502.9 $ 1,003.8
Specialty Engineered Materials 240.6 158.8 457.1 344.1 708.8 745.7
Distribution 404.4 238.8 767.1 528.3 1,110.3 1,192.2
Corporate and eliminations (34.2) (15.3) (60.4) (35.1) (79.9) (79.0)
Sales $ 1,235.2 $ 609.1 $ 2,397.5 $ 1,320.6 $ 3,242.1 $ 2,862.7
Operating income:
Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 180.8 $ 147.4 $ 158.5
Specialty Engineered Materials 37.3 17.0 71.5 94.4 83.7 72.3
Distribution 23.7 14.6 47.7 69.5 75.4 71.5
Corporate and eliminations (39.2) (25.9) (65.8) (155.4) (149.7) (123.7)
Operating income $ 108.1 $ 38.0 $ 228.5 $ 189.3 $ 156.8 $ 178.6
Items below OI in Corporate:
Other income, net $ 1.2 $ 9.5 $ 2.7 $ 24.3 $ 12.1 $ (12.9)
Depreciation & amortization:
Color, Additives and Inks $ 25.3 $ 10.6 $ 52.6 $ 75.1 $ 42.7 $ 44.3
Specialty Engineered Materials 8.1 7.6 15.9 30.0 29.5 23.2
Distribution 0.2 0.1 0.4 0.7 0.5 0.7
Corporate and eliminations 0.2 2.6 2.0 9.2 5.4 4.4
Depreciation & Amortization $ 33.8 $ 20.9 $ 70.9 $ 115.0 $ 78.1 $ 72.6
EBITDA:
Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 255.9 $ 190.1 $ 202.8
Specialty Engineered Materials 45.4 24.6 87.4 124.4 113.2 95.5
Distribution 23.9 14.7 48.1 70.2 75.9 72.2
Corporate and eliminations (39.0) (23.3) (63.8) (146.2) (144.3) (119.3)
EBITDA $ 143.1 $ 68.4 $ 302.1 $ 328.6 $ 247.0 $ 238.3
EBITDA as a % of Sales:
Color, Additives and Inks 17.9 % 18.9 % 18.5 % 17.0 % 18.9 % 19.4 %
Specialty Engineered Materials 18.9 % 15.5 % 19.1 % 17.6 % 15.2 % 14.8 %
Distribution 5.9 % 6.2 % 6.3 % 6.3 % 6.4 % 5.7 %
2
Reconciliation of Pro Forma EBITDA
- Color, Additives and Inks
Three Months Ended
June 30,
Six
Months
Ended
Year Ended
December 31,
2021 2020 2021 2020 2019 2018
Sales:
Color, Additives and Inks $ 624.4 $ 226.8 $ 1,233.7 $ 1,502.9 $ 1,003.8 $ 1,046.5
Clariant MB pro forma
adjustments(1) — 261.1 — 540.4 1,118.6 1,209.8
Pro forma sales $ 624.4 $ 487.9 $ 1,233.7 $ 2,043.3 $ 2,122.4 $ 2,256.3
Operating income:
Color, Additives and Inks $ 86.3 $ 32.3 $ 175.1 $ 180.8 $ 147.4 $ 158.5
Clariant MB pro forma
adjustments(1) — 22.0 — 45.0 72.9 80.3
Pro forma operating income $ 86.3 $ 54.3 $ 175.1 $ 225.8 $ 220.3 $ 238.8
Depreciation & amortization:
Color, Additives and Inks $ 25.3 $ 10.6 $ 52.6 $ 75.1 $ 42.7 $ 44.3
Clariant MB pro forma adjustments(1) — 15.0 — 30.1 60.3 61.2
Pro forma depreciation & amortization $ 25.3 $ 25.6 $ 52.6 $ 105.2 $ 103.0 $ 105.5
EBITDA
Color, Additives and Inks $ 111.6 $ 42.9 $ 227.7 $ 255.9 $ 190.1 $ 202.8
Clariant MB pro forma
adjustments(1) — 37.0 — 75.1 133.2 141.5
Pro forma EBITDA $ 111.6 $ 79.9 $ 227.7 $ 331.0 $ 323.3 $ 344.3
Pro forma EBITDA as a % of Sales 17.9 % 16.4 % 18.5 % 16.2 % 15.2 % 15.3 %
Three Months Ended
June 30, 2020
Reconciliation of Pro Forma Adjusted Earnings per
Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Pro Forma
Adjusted
Sales $ 609.1 $ — $ 609.1 $ 261.1 $ 870.2
Operating income $ 38.0 $ 9.0 $ 47.0 $ 22.0 $ 69.0
Interest expense, net (16.2) — (16.2) (5.3) (21.5)
Other income, net 9.5 (6.6) 2.9 — 2.9
Income taxes (7.9) 0.2 (7.7) (3.8) (11.5)
Net income attributable to noncontrolling interests (0.4) — (0.4) — (0.4)
Net income from continuing operations attributable to
Avient shareholders $ 23.0 $ 2.6 $ 25.6 $ 12.9 $ 38.5
Weighted average diluted shares 91.8
Pro forma adjusted EPS $ 0.42
3
December 31, 2020
Reconciliation of Pro Forma Adjusted
Earnings per Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Pro Forma
Adjusted
Sales $ 3,242.1 $ — $ 3,242.1 $ 540.4 $ 3,782.5
Operating income $ 189.3 $ 73.7 $ 263.0 $ 45.0 $ 308.0
Interest expense, net (74.6) 10.1 (64.5) (18.1) (82.6)
Other income, net 24.3 (17.6) 6.7 — 6.7
Income taxes (5.2) (41.4) (46.6) (6.2) (52.8)
Net income attributable to noncontrolling
interests (1.8) — (1.8) — (1.8)
Net income from continuing operations
attributable to Avient shareholders $ 132.0 $ 24.8 $ 156.8 $ 20.7 $ 177.5
Weighted average diluted shares 90.6
Impact to diluted shares from January 2020 equity offering 1.5
Pro forma weighted average diluted shares 92.1
Pro forma adjusted EPS $ 1.93
December 31, 2019
Reconciliation of Pro Forma Adjusted
Earnings per Share Avient
Special
Adjusted
Clariant MB
Pro Forma
Pro Forma
Adjusted
Sales $ 2,862.7 $ — $ 2,862.7 $ 1,118.6 $ 3,981.3
Operating income $ 156.8 $ 71.7 $ 228.5 $ 72.9 $ 301.4
Interest expense, net (59.5) — (59.5) (33.4) (92.9)
Other income, net 12.1 (10.0) 2.1 — 2.1
Income taxes (33.7) (5.9) (39.6) (9.1) (48.7)
Net income attributable to noncontrolling
interests (0.2) — (0.2) — (0.2)
Net income from continuing operations
attributable to Avient shareholders $ 75.5 $ 55.8 $ 131.3 $ 30.4 $ 161.7
Weighted average diluted shares 77.7
Impact to diluted shares from January 2020 equity offering 15.3
Pro forma weighted average diluted shares 93.0
Pro forma adjusted EPS $ 1.74
4
AVNT Seaport Conference Presentation.pdf
AVNT Q2 2021 Earnings Presentation - Website.pdf
AVNT Q2 2021 Earnings Presentation - Website.pdf
Final - 7.19 1158am Q2 21 IR Deck Version v2
https://www.avient.com/sites/default/files/2023-08/Avient General Purchase Conditions.pdf
Section 307 of the Tariff Act of
1930 (19 U.S.C. § 1307), in the manufacture or
supply of any materials or services for Avient.
Section 307 of the Tariff Act of
1930 (19 U.S.C. § 1307) and Trade Facilitation
and Enforcement Act of 2015 (TFTEA) including
the applicable provisions of the Uyghur Forced
Labor Prevention Act (UFLPA).
In the event of termination
for cause, Avient shall not be liable to Supplier
for any amount, and Supplier shall be liable to
Avient for any and all damages sustained by
reason of the default which gave rise to the
termination.
18.2 Upon termination, Supplier will return
all Data and all other information belonging to or
provided by Avient to Supplier and all copies of
such Data and information to Avient forthwith,
including, but not limited to any and all
information under clause 15, or, at the written
instruction of Avient, will destroy all such Data
and information together with any and all copies
of all such Data and information and certify in
writing to Avient thereof.
19.
https://www.avient.com/sites/default/files/resources/PolyOne%25202018%2520Proxy%2520Statement.PDF
a solar silicon
company, from August 2010 to 2011.
On July 19, 2017, we completed the sale of our DSS business to
Arsenal Capital Partners.
Axiall Corporation was acquired in August 2016 and was therefore removed from the peer group for 2018
compensation consideration and beyond.
https://www.avient.com/sites/default/files/2023-11/Responsible Care_14001 Global Cert_Avient.pdf
Industrial Valle del Cinca S/N Apartado
Barbastro, Huesca E-22300
Facility: Avient Corporation - Bethel, CT
19 Francis J Clark Circle
Bethel, CT 06801
Activity: Design and Manufacture of Specialty Engineered Thermoplastics Activity: Design and Manufacture of Colorants and Compounds for
Fluoropolymer and High Temperature Polymers.
https://www.avient.com/sites/default/files/2023-11/ISO14001 Global Cert_Avient.pdf
Industrial Valle del Cinca S/N Apartado
Barbastro, Huesca E-22300
Facility: Avient Corporation - Bethel, CT
19 Francis J Clark Circle
Bethel, CT 06801
Activity: Design and Manufacture of Specialty Engineered Thermoplastics Activity: Design and Manufacture of Colorants and Compounds for
Fluoropolymer and High Temperature Polymers.